RIA
EBS icon

Realta Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Realta Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,320
Closed -$308K – 400
2021
Q1 		$308K Sell
3,320
-2,211
-40% -$226K 0.08% 269
2020
Q4 		$496K Sell
5,531
-1,606
-23% -$147K 0.14% 167
2020
Q3 		$737K Buy
7,137
+460
+7% +$49.6K 0.25% 95
2020
Q2 		$528K Buy
+6,677
New +$498K 0.17% 154
2019
Q2 		– Sell
-36
Closed -$2K – 1727
2019
Q1 		$2K Buy
+36
New +$2.12K ﹤0.01% 1206

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Realta Investment Advisors's EBS Position: Q2 2021 in Review

Realta Investment Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 3,320 shares — an estimated $308K sold.

Realta Investment Advisors first reported a position in EBS in Q1 2019 and held it in 5 quarters. The position peaked at $737K in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Realta Investment Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Realta Investment Advisors sold 3,320 Emergent Biosolutions shares in Q2 2021, an estimated $308K.
  • Realta Investment Advisors first reported a position in Emergent Biosolutions in Q1 2019 and held it in 5 quarters.
  • Realta Investment Advisors's Emergent Biosolutions position peaked at $737K in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Realta Investment Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.